{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:23:22Z","timestamp":1789219402441,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012581","name":"The Macula Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.oret.2024.07.024","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:08:01Z","timestamp":1722654481000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Safety of Anti-VEGF Injections and Surgery for Age-Related Macular Degeneration-Related Submacular Hemorrhage"],"prefix":"10.1016","volume":"9","author":[{"given":"Abdulla","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divy","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyedehfatemeh","family":"Ghalibafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Buali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugi","family":"Panneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hoyek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry W.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2024.07.024_bib1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2024.07.024_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.07.024_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.survophthal.2015.04.004","article-title":"Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature","volume":"61","author":"Stanescu-Segall","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000360469","article-title":"Subretinal hemorrhage","volume":"54","author":"Yiu","year":"2014","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib5","doi-asserted-by":"crossref","first-page":"e1569","DOI":"10.1111\/aos.15137","article-title":"Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry","volume":"100","author":"Gabrielle","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/eye.2015.131","article-title":"Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration","volume":"29","author":"Kim","year":"2015","journal-title":"Eye (Lond Engl)"},{"key":"10.1016\/j.oret.2024.07.024_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40942-020-00228-x","article-title":"Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods","volume":"6","author":"Grohmann","year":"2020","journal-title":"Int J Retina Vitr"},{"key":"10.1016\/j.oret.2024.07.024_bib8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00417-022-05885-2","article-title":"Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration","volume":"261","author":"Weber","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib9","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2024.07.024_bib11","series-title":"Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields","author":"Kmet","year":"2004"},{"key":"10.1016\/j.oret.2024.07.024_bib12","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11136-021-02814-4","article-title":"Enhancing validity, reliability and participation in self-reported health outcome measurement for children and young people: a systematic review of recall period, response scale format, and administration modality","volume":"30","author":"Coombes","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.oret.2024.07.024_bib13","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1111\/aos.15045","article-title":"Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator","volume":"100","author":"Caporossi","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3928\/1542-8877-19990301-04","article-title":"Preoperative use of tissue plasminogen activator for large submacular hemorrhage","volume":"30","author":"Chaudhry","year":"1999","journal-title":"Ophthal Surg Lasers"},{"key":"10.1016\/j.oret.2024.07.024_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1159\/000526068","article-title":"Intravitreal r-tPA injection and pneumatic displacement for submacular retinal hemorrhage: a case series","volume":"13","author":"Confalonieri","year":"2022","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9394(88)90116-X","article-title":"Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration","volume":"105","author":"de Juan","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib17","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/IAE.0000000000001030","article-title":"Tissue plasminogen activator for subfoveal hemorrhage due to age-related macular degeneration: Comparison of 3 treatment modalities","volume":"36","author":"Fassbender","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2024.07.024_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/ICB.0b013e31818a470e","article-title":"Surgical management of massive submacular hemorrhage associated with age-related macular degeneration","volume":"3","author":"Gibran","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2024.07.024_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4103\/ijo.IJO_129_16","article-title":"Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration","volume":"65","author":"Gok","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archopht.1995.01100010064022","article-title":"Surgical management of submacular hemorrhage. A series of 47 consecutive cases","volume":"113","author":"Ibanez","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib21","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41433-022-02222-z","article-title":"Na\u00efve subretinal haemorrhage due to neovascular age-related macular degeneration. Pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept\u2014the native study","volume":"37","author":"Iglicki","year":"2023","journal-title":"Eye (Lond Engl)"},{"key":"10.1016\/j.oret.2024.07.024_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3928\/23258160-20130909-09","article-title":"Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning","volume":"44","author":"Kapran","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2024.07.024_bib23","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1177\/1120672120959551","article-title":"Comparison between different techniques for treatment of submacular haemorrhage due to age-related macular degeneration","volume":"31","author":"Kishikova","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib24","first-page":"19","article-title":"Surgical removal of subretinal hemorrhage and choroidal neovascular membranes in acute hemorrhagic age-related macular degeneration","volume":"28","author":"Mandelcorn","year":"1993","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1442-9071.1994.tb01697.x","article-title":"Tissue plasminogen activator in the surgical management of subretinal haemorrhage","volume":"22","author":"Manning","year":"1994","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.5301\/ejo.5000500","article-title":"Vitrectomy and subretinal injection of tissue plasminogen activator for large submacular hemorrhage secondary to AMD","volume":"24","author":"Moisseiev","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/eye.1995.144","article-title":"Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage","volume":"9","author":"Moriarty","year":"1995","journal-title":"Eye (Lond Engl)"},{"key":"10.1016\/j.oret.2024.07.024_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.sjopt.2018.08.002","article-title":"Submacular hemorrhage secondary to age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, hemorrhage displacement with liquid perfluorocarbon, gas tamponade, and face-down positioning","volume":"32","author":"Ozkaya","year":"2018","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib29","first-page":"575","article-title":"Tissue plasminogen activating factor assisted removal of subretinal hemorrhage","volume":"22","author":"Peyman","year":"1991","journal-title":"Ophthal Surg"},{"key":"10.1016\/j.oret.2024.07.024_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s004170050187","article-title":"Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study","volume":"237","author":"Scheider","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib31","first-page":"98","article-title":"Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage\/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement","volume":"103","author":"Thompson","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2024.07.024_bib32","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s10792-021-01976-x","article-title":"Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review","volume":"41","author":"Tranos","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.ieb.0000158900.09393.2d","article-title":"Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration ophthalmic findings SST Report no. 13","volume":"6","author":"Vander","year":"2005","journal-title":"Evid Based Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0161-6420(91)32348-0","article-title":"Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration","volume":"98","author":"Vander","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.07.024_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00417-019-04474-0","article-title":"Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"258","author":"Kim","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/IAE.0b013e3181dd6d8a","article-title":"Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration","volume":"30","author":"Chang","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.oret.2024.07.024_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/IAE.0000000000000295","article-title":"Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration","volume":"35","author":"Cho","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2024.07.024_bib38","first-page":"173","article-title":"Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration","volume":"9","author":"Dikmetas","year":"2022","journal-title":"North Clin Istanb"},{"key":"10.1016\/j.oret.2024.07.024_bib39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2147\/OPTH.S87919","article-title":"Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy","volume":"9","author":"Dimopoulos","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib40","first-page":"281","article-title":"Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration","volume":"34","author":"Iacono","year":"2014","journal-title":"RETINA- J Retin Vitr Dis"},{"key":"10.1016\/j.oret.2024.07.024_bib41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/0301-4738.119432","article-title":"Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration","volume":"61","author":"Jain","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2018.02.015","article-title":"Shortest distance from fovea to subfoveal hemorrhage border is important in patients with neovascular age-related macular degeneration","volume":"189","author":"Kherani","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ophtha.2013.11.004","article-title":"Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization","volume":"121","author":"Kim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.07.024_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0031-1273214","article-title":"Intravitreal ranibizumab in the treatment of predominantly hemorrhagic lesions in exudative age-related macular degeneration","volume":"228","author":"Konstantinidis","year":"2011","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.oret.2024.07.024_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000371393","article-title":"Intravitreal ranibizumab for predominantly hemorrhagic choroidal neovascularization in age-related macular degeneration","volume":"233","author":"Lazzeri","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2024.07.024_bib46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/eye.2009.271","article-title":"Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration","volume":"24","author":"McKibbin","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.oret.2024.07.024_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajo.2021.09.033","article-title":"Associations and outcomes of patients with submacular hemorrhage secondary to age-related macular degeneration in the IVAN Trial","volume":"236","author":"Mehta","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib48","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1038\/s41598-022-18619-5","article-title":"Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy","volume":"12","author":"Mun","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2024.07.024_bib50","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/eye.2008.267","article-title":"Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration","volume":"23","author":"Sacu","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.oret.2024.07.024_bib51","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ajo.2013.01.012","article-title":"Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy","volume":"155","author":"Shienbaum","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib52","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1038\/s41598-023-32874-0","article-title":"Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage","volume":"13","author":"Maruyama-Inoue","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2024.07.024_bib53","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajo.2007.07.034","article-title":"Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage","volume":"144","author":"Stifter","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.07.024_bib54","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","article-title":"Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?","volume":"22","author":"Uludag","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.oret.2024.07.024_bib55","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-vision-100419-115156","article-title":"Retina metabolism and metabolism in the pigmented epithelium: a busy intersection","volume":"7","author":"Hurley","year":"2021","journal-title":"Annu Rev Vis Sci"},{"key":"10.1016\/j.oret.2024.07.024_bib56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/11206721231202048","article-title":"Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration","volume":"34","author":"Barayev","year":"2024","journal-title":"Eur J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024003592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024003592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T08:13:47Z","timestamp":1735805627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653024003592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2468653024003592"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2024.07.024","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Anti-VEGF Injections and Surgery for Age-Related Macular Degeneration-Related Submacular Hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2024.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}